The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Steady-state hyperaemia: many routes, one goal

EuroIntervention 2020;16:532-533. DOI: 10.4244/EIJV16I7A98

1. University Heart Center Graz, Division of Cardiology, Medical University Graz, Graz, Austria; 2. Cardiovascular Research Center Aalst, OLV Clinic, Aalst, Belgium; 3. Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland

The HYPEREMIC trial by Elghamaz et al1 describes the use of a 3 Fr over-the-wire microcatheter for inducing maximal coronary hyperaemia during fractional flow reserve (FFR) measurement.

Forty-one patients sequentially received intravenous and intracoronary adenosine in a randomly alternated order. The data indicate that intracoronary administration of adenosine through the microcatheter allows a total dose reduction of two magnitudes and makes it possible to reach maximal hyperaemia in half the time compared to conventional intravenous administration. Patient discomfort is also markedly reduced when the intracoronary route is used. The authors do not provide analysis data about test-retest variability but ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Functional assessment 3.0: from wire through angio to OCT